Noto<wbr/>ginsenoside R1

Notoginsenoside R1

CAT N°: 29691
Price:

From 108.00 91.80

Notoginsenoside R1 is a saponin that has been found in P. notoginseng and has diverse biological activities, including cardioprotective, neuroprotective, and anti-inflammatory properties.{48858} It decreases serum total cholesterol, triacylglycerol, and oxidized LDL (oxLDL) levels, as well as reduces atherosclerotic lesion area and lipid deposition in the aortic root of ApoE-/- mice fed a Western diet when administered at a dose of 25 mg/kg per day for eight weeks.{48859} Notoginsenoside R1 (100 mg/kg) inhibits apoptosis of hippocampal neurons and reduces infarct size in a rat model of cerebral ischemia-reperfusion injury induced by bilateral common carotid artery occlusion.{48860} It decreases colonic NF-?B and myeloperoxidase (MPO) activities and TNF-? and IL-6 levels, as well as reduces colonic shortening, tissue damage, and inflammatory cell infiltration in a mouse model of colitis induced by dextran sulfate sodium (DSS; Item No. 23250) when administered at a dose of 25 mg/kg per day for seven days.{48861}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (3?,6?,12?)-20-(?-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-?-D-xylopyranosyl-?-D-glucopyranoside
  • Correlated keywords
    • R 1 Panax cardio neuro protective antiinflammatory triacyl glycerol Apo E NF?B TNF? IL6 interleukin Sanqi glucoside
  • Product Overview:
    Notoginsenoside R1 is a saponin that has been found in P. notoginseng and has diverse biological activities, including cardioprotective, neuroprotective, and anti-inflammatory properties.{48858} It decreases serum total cholesterol, triacylglycerol, and oxidized LDL (oxLDL) levels, as well as reduces atherosclerotic lesion area and lipid deposition in the aortic root of ApoE-/- mice fed a Western diet when administered at a dose of 25 mg/kg per day for eight weeks.{48859} Notoginsenoside R1 (100 mg/kg) inhibits apoptosis of hippocampal neurons and reduces infarct size in a rat model of cerebral ischemia-reperfusion injury induced by bilateral common carotid artery occlusion.{48860} It decreases colonic NF-?B and myeloperoxidase (MPO) activities and TNF-? and IL-6 levels, as well as reduces colonic shortening, tissue damage, and inflammatory cell infiltration in a mouse model of colitis induced by dextran sulfate sodium (DSS; Item No. 23250) when administered at a dose of 25 mg/kg per day for seven days.{48861}

We also advise you